
    
      This is the first academic registry study about adverse events or adverse drug reaction for
      Chinese medicine injection in mainland China.

      It is well known that Chinese medicine injection is just limited in mainland China, which
      also be accepted by China health care system.

      However, more and more adverse events or adverse drug reaction have been reported in recent
      years in the form of case report.

      In order to improving monitoring adverse events or adverse drug reaction of Chinese medicine
      injection in hospital, registry study will be introduced in this area.

      To calculate the incidence of adverse events or adverse drug reaction is one of the main aims
      for this study.

      According to the 'rule of three', 30,000 cases need to be registered at least.
    
  